Exact Sciences Corporation Statistics
Share Statistics
Exact Sciences Corporation has 185.08M shares outstanding. The number of shares has increased by 2.17% in one year.
Shares Outstanding | 185.08M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 0.13% |
Owned by Institutions (%) | n/a |
Shares Floating | 182.38M |
Failed to Deliver (FTD) Shares | 500 |
FTD / Avg. Volume | 0.02% |
Short Selling Information
The latest short interest is 14.06M, so 7.6% of the outstanding shares have been sold short.
Short Interest | 14.06M |
Short % of Shares Out | 7.6% |
Short % of Float | 7.71% |
Short Ratio (days to cover) | 9.68 |
Valuation Ratios
The PE ratio is -65.28 and the forward PE ratio is -147.53.
PE Ratio | -65.28 |
Forward PE | -147.53 |
PS Ratio | 5.33 |
Forward PS | 3.5 |
PB Ratio | 4.24 |
P/FCF Ratio | 417.4 |
PEG Ratio | n/a |
Enterprise Valuation
Exact Sciences Corporation has an Enterprise Value (EV) of 15.28B.
EV / Earnings | -74.83 |
EV / Sales | 6.11 |
EV / EBITDA | 364.8 |
EV / EBIT | -71.05 |
EV / FCF | 478.45 |
Financial Position
The company has a current ratio of 2.32, with a Debt / Equity ratio of 0.75.
Current Ratio | 2.32 |
Quick Ratio | 2.07 |
Debt / Equity | 0.75 |
Total Debt / Capitalization | 42.91 |
Cash Flow / Debt | 0.07 |
Interest Coverage | -8.8 |
Financial Efficiency
Return on equity (ROE) is -0.06% and return on capital (ROIC) is -3.82%.
Return on Equity (ROE) | -0.06% |
Return on Assets (ROA) | -0.03% |
Return on Capital (ROIC) | -3.82% |
Revenue Per Employee | 384.58K |
Profits Per Employee | -31.41K |
Employee Count | 6.50K |
Asset Turnover | 0.39 |
Inventory Turnover | 5.13 |
Taxes
Income Tax | 2.40M |
Effective Tax Rate | -0.01 |
Stock Price Statistics
The stock price has increased by -6.86% in the last 52 weeks. The beta is 1.27, so Exact Sciences Corporation's price volatility has been higher than the market average.
Beta | 1.27 |
52-Week Price Change | -6.86% |
50-Day Moving Average | 62.96 |
200-Day Moving Average | 58.23 |
Relative Strength Index (RSI) | 55.48 |
Average Volume (20 Days) | 2.54M |
Income Statement
In the last 12 months, Exact Sciences Corporation had revenue of $2.50B and earned -$204.15M in profits. Earnings per share was $-1.13.
Revenue | 2.50B |
Gross Profit | 1.85B |
Operating Income | -215.01M |
Net Income | -204.15M |
EBITDA | 41.88M |
EBIT | -215.01M |
Earnings Per Share (EPS) | -1.13 |
Balance Sheet
The company has $605.38M in cash and $2.55B in debt, giving a net cash position of -$1.95B.
Cash & Cash Equivalents | 605.38M |
Total Debt | 2.55B |
Net Cash | -1.95B |
Retained Earnings | -3.47B |
Total Assets | 6.75B |
Working Capital | 809.46M |
Cash Flow
In the last 12 months, operating cash flow was $156.12M and capital expenditures -$124.19M, giving a free cash flow of $31.93M.
Operating Cash Flow | 156.12M |
Capital Expenditures | -124.19M |
Free Cash Flow | 31.93M |
FCF Per Share | 0.18 |
Margins
Gross margin is 73.83%, with operating and profit margins of -8.6% and -8.17%.
Gross Margin | 73.83% |
Operating Margin | -8.6% |
Pretax Margin | -8.07% |
Profit Margin | -8.17% |
EBITDA Margin | 1.68% |
EBIT Margin | -8.6% |
FCF Margin | 1.28% |
Dividends & Yields
EXAS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -1.84% |
FCF Yield | 0.28% |
Analyst Forecast
The average price target for EXAS is $72, which is 17.3% higher than the current price. The consensus rating is "Buy".
Price Target | $72 |
Price Target Difference | 17.3% |
Analyst Consensus | Buy |
Analyst Count | 18 |
Scores
Altman Z-Score | 1.68 |
Piotroski F-Score | 3 |